More Views

VIJAYA CAPSULES (Cannabis sativa) CBD:THC 1:1

Relieves Neuropathic Pain, Stimulates Appetite.

Be the first to review this product

Availability: In stock

₹230.00
Reward Points You will earn 23 Points for purchasing this product.
-
+

Product Details

Cannabis has been used since thousands of years to reduce pain, control nausea, stimulate appetite, relax muscles, improve sleep, reduce anxiety, manage seizures and produce a feeling of euphoria. The therapeutic benefits of Cannabis are derived from the interactions of cannabinoids and our own endocannabinoid system. ECS is a collection of neuromodulators, their receptors, and signaling pathways involved in regulating movement, mood, memory, appetite, pain and many other activities.

This full spectrum cannabis extract is standardized to 4% CBD & 4%THC.

THERAPEUTIC BENEFITS

CBD is able to block the actions of compounds such as THC, which activates CB1 and CB2 receptors. Consequently it can suppress the psychoactive effects of THC.

  • Is effective for treating chemotherapy-induced nausea and vomiting
  • Stimulates Appetite and treats upset stomach
  • Is useful for Cancer palliative care
  • Treats glaucoma, insomnia, knee pain, muscle cramp, back pain
  • Useful in the treatment of Alzheimer’s, Parkinson's and other neurodegenerative diseases
  • Prevents cancer
  • Is an effective remedy for autism, epilepsy, neuropathic disorder, and multiple sclerosis
  • Is a good source to control blood sugar
  • Is also useful in combating alcoholism and other harmful drug addiction.

ACTIVE CONSTITUENTS

Cannabidiol (CBD), delta-9-tetrahydrocannabinol (THC) and Other Cannabinoids.

Ingredients

Each 125mg Capsule contains: Each Capsule contains 125mg of Cannabis extract infused in Organic cold-pressed Coconut oil

Additional Information

DOSAGE: 1 - 2 capsules twice a day after food or as directed by the physician.

CLINICAL STUDY

Neuropathic Pain

A randomised, double-blind, placebo-controlled, parallel design trial was conducted on 125 patients for five weeks. Sixty-three patients were randomised to receive sativex (Cannabis 1:1::CBD:THC) and 62 placebo. The mean reduction in pain intensity scores (primary outcome measure) was greater in patients receiving sativex.

Ref: Nurmikko T.J. et. al., Sativex successfully treats neuropathic pain characterised by allodynia: a randomised, double-blind, placebo-controlled clinical trial. Pain., 2007, 133(1-3):210-20.

Multiple Sclerosis

On a randomized controlled trial of Cannabis (CBD:THC::1:1) in 135 randomized subjects with MS and overactive bladder (OAB) for a 10 week long treatment, some improvement in symptoms associated with bladder dysfunction observed.

Ref: Kavia R.B. et. al., Randomized controlled trial of Sativex to treat detrusor overactivity in multiple sclerosis. Mult Scler. 2010, 16(11): 1349-59

CAUTION:

  • It is NOT recommended for pediatric patient.
  • It is advised to start with a low dose and increase the dose in every 4 days consulting with your physician.
  • It contains Schedule E-1 Drug. So do NOT take this without the consent of physician.
  • Patients should not drive or operate machinery while under cannabis treatment.

Shipping & Returns

Your shipment will be delivered within 2 to 15 business days (Depending on your location).


For purchases of Rs 500 and above, shipping is free. A shipping charge of Rs 60 will be added for purchases below Rs 500.


For more on our shipping policy, please go through our Terms and Conditions.

testimonials

No

close button
close button